{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:14:33Z","timestamp":1790018073096,"version":"4.0.1"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T00:00:00Z","timestamp":1718582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T00:00:00Z","timestamp":1718582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100013209","name":"Hellenic Foundation for Research and Innovation","doi-asserted-by":"publisher","award":["1855"],"award-info":[{"award-number":["1855"]}],"id":[{"id":"10.13039\/501100013209","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003447","name":"State Scholarships Foundation","doi-asserted-by":"publisher","award":["2022-050-0502-52303"],"award-info":[{"award-number":["2022-050-0502-52303"]}],"id":[{"id":"10.13039\/501100003447","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A link between chronic stress and Parkinson\u2019s disease (PD) pathogenesis is emerging. Ample evidence demonstrates that the presynaptic neuronal protein alpha-synuclein (asyn) is closely tied to PD pathogenesis. However, it is not known whether stress system dysfunction is present in PD, if asyn is involved, and if, together, they contribute to neurodegeneration. To address these questions, we assess stress axis function in transgenic rats overexpressing full-length wildtype human asyn (asyn BAC rats) and perform multi-level stress and PD phenotyping following chronic corticosterone administration. Stress signaling, namely corticotropin-releasing factor, glucocorticoid and mineralocorticoid receptor gene expression, is also examined in post-mortem PD patient brains. Overexpression of human wildtype asyn leads to HPA axis dysregulation in rats, while chronic corticosterone administration significantly aggravates nigrostriatal degeneration, serine129 phosphorylated asyn (pS129) expression and neuroinflammation, leading to phenoconversion from a prodromal to an overt motor PD phenotype. Interestingly, chronic corticosterone in asyn BAC rats induces a robust, twofold increase in pS129 expression in the hypothalamus, the master regulator of the stress response, while the hippocampus, both a regulator and a target of the stress response, also demonstrates elevated pS129 asyn levels and altered markers of stress signalling. Finally, defective hippocampal stress signalling is mirrored in human PD brains and correlates with asyn expression levels. Taken together, our results link brain stress system dysregulation with asyn and provide evidence that elevated circulating glucocorticoids can contribute to asyn-induced neurodegeneration, ultimately triggering phenoconversion from prodromal to overt PD.<\/jats:p>","DOI":"10.1186\/s40478-024-01797-w","type":"journal-article","created":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T08:02:18Z","timestamp":1718611338000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Alpha-synuclein-induced stress sensitivity renders the Parkinson\u2019s disease brain susceptible to neurodegeneration"],"prefix":"10.1186","volume":"12","author":[{"given":"Modestos","family":"Nakos Bimpos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Karali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Antoniou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dionysios","family":"Palermos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Fouka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasios","family":"Delis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iason","family":"Tzieras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George Panagiotis","family":"Chrousos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yassemi","family":"Koutmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonidas","family":"Stefanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexia","family":"Polissidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,17]]},"reference":[{"key":"1797_CR1","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/S1474-4422(19)30029-8","volume":"18","author":"WM Carroll","year":"2019","unstructured":"Carroll WM (2019) The global burden of neurological disorders. Lancet Neurol 18:418\u2013419. https:\/\/doi.org\/10.1016\/S1474-4422(19)30029-8","journal-title":"Lancet Neurol"},{"key":"1797_CR2","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.3233\/JPD-181474","volume":"8","author":"ER Dorsey","year":"2018","unstructured":"Dorsey ER, Sherer T, Okun MS, Bloem BR (2018) The emerging evidence of the parkinson pandemic. J Park Dis 8:S3\u2013S8. https:\/\/doi.org\/10.3233\/JPD-181474","journal-title":"J Park Dis"},{"key":"1797_CR3","doi-asserted-by":"publisher","first-page":"a008888","DOI":"10.1101\/cshperspect.a008888","volume":"2","author":"C Klein","year":"2012","unstructured":"Klein C, Westenberger A (2012) Genetics of Parkinson\u2019s Disease. Cold Spring Harb Perspect Med 2:a008888. https:\/\/doi.org\/10.1101\/cshperspect.a008888","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1797_CR4","doi-asserted-by":"publisher","first-page":"a009399","DOI":"10.1101\/cshperspect.a009399","volume":"2","author":"L Stefanis","year":"2012","unstructured":"Stefanis L (2012) \u03b1-Synuclein in Parkinson\u2019s Disease. Cold Spring Harb Perspect Med 2:a009399. https:\/\/doi.org\/10.1101\/cshperspect.a009399","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1797_CR5","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.tins.2018.09.007","volume":"42","author":"ME Johnson","year":"2019","unstructured":"Johnson ME, Stecher B, Labrie V, Brundin L, Brundin P (2019) Triggers, facilitators, and aggravators: redefining Parkinson\u2019s disease pathogenesis. Trends Neurosci 42:4\u201313. https:\/\/doi.org\/10.1016\/j.tins.2018.09.007","journal-title":"Trends Neurosci"},{"key":"1797_CR6","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/00005053-188702000-00011","volume":"14","author":"WR Gowers","year":"1887","unstructured":"Gowers WR (1887) A manual of diseases of the nervous system. J Nerv Ment Dis 14:123","journal-title":"J Nerv Ment Dis"},{"key":"1797_CR7","doi-asserted-by":"publisher","first-page":"14436","DOI":"10.1523\/JNEUROSCI.3836-11.2011","volume":"31","author":"JC Carroll","year":"2011","unstructured":"Carroll JC, Iba M, Bangasser DA, Valentino RJ, James MJ, Brunden KR, Lee VM-Y, Trojanowski JQ (2011) Chronic stress exacerbates tau pathology, neurodegeneration, and cognitive performance through a corticotropin-releasing factor receptor-dependent mechanism in a transgenic mouse model of tauopathy. J Neurosci 31:14436\u201314449. https:\/\/doi.org\/10.1523\/JNEUROSCI.3836-11.2011","journal-title":"J Neurosci"},{"key":"1797_CR8","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1016\/j.neubiorev.2012.07.001","volume":"36","author":"MN Hill","year":"2012","unstructured":"Hill MN, Hellemans KGC, Verma P, Gorzalka BB, Weinberg J (2012) Neurobiology of chronic mild stress: parallels to major depression. Neurosci Biobehav Rev 36:2085\u20132117. https:\/\/doi.org\/10.1016\/j.neubiorev.2012.07.001","journal-title":"Neurosci Biobehav Rev"},{"key":"1797_CR9","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1136\/jnnp-2013-305911","volume":"85","author":"A Djamshidian","year":"2014","unstructured":"Djamshidian A, Lees AJ (2014) Can stress trigger Parkinson\u2019s disease? J Neurol Neurosurg Psychiatry 85:878\u2013881. https:\/\/doi.org\/10.1136\/jnnp-2013-305911","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1797_CR10","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/mp.2013.108","volume":"19","author":"AM Hemmerle","year":"2014","unstructured":"Hemmerle AM, Dickerson JW, Herman JP, Seroogy KB (2014) Stress exacerbates experimental Parkinson\u2019s disease. Mol Psychiatry 19:638\u2013640. https:\/\/doi.org\/10.1038\/mp.2013.108","journal-title":"Mol Psychiatry"},{"key":"1797_CR11","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.expneurol.2016.09.004","volume":"285","author":"Q Wu","year":"2016","unstructured":"Wu Q, Yang X, Zhang Y, Zhang L, Feng L (2016) Chronic mild stress accelerates the progression of Parkinson\u2019s disease in A53T \u03b1-synuclein transgenic mice. Exp Neurol 285:61\u201371. https:\/\/doi.org\/10.1016\/j.expneurol.2016.09.004","journal-title":"Exp Neurol"},{"key":"1797_CR12","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3389\/fpsyt.2015.00032","volume":"6","author":"X Du","year":"2015","unstructured":"Du X, Pang TY (2015) Is Dysregulation of the HPA-axis a core pathophysiology mediating co-morbid depression in neurodegenerative diseases? Front Psychiatry 6:32. https:\/\/doi.org\/10.3389\/fpsyt.2015.00032","journal-title":"Front Psychiatry"},{"key":"1797_CR13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.neurobiolaging.2019.08.007","volume":"83","author":"J Burtscher","year":"2019","unstructured":"Burtscher J, Copin J-C, Rodrigues J, Kumar ST, Chiki A, Guillot de Suduiraut I, Sandi C, Lashuel HA (2019) Chronic corticosterone aggravates behavioral and neuronal symptomatology in a mouse model of alpha-synuclein pathology. Neurobiol Aging 83:11\u201320. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2019.08.007","journal-title":"Neurobiol Aging"},{"key":"1797_CR14","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/mds.28383","volume":"36","author":"A Polissidis","year":"2021","unstructured":"Polissidis A, Koronaiou M, Kollia V, Koronaiou E, Nakos-Bimpos M, Bogiongko M, Vrettou S, Karali K, Casadei N, Riess O, Sardi SP, Xilouri M, Stefanis L (2021) Psychosis-like behavior and hyperdopaminergic dysregulation in human \u03b1-synuclein BAC transgenic rats. Mov Disord 36:716\u2013728. https:\/\/doi.org\/10.1002\/mds.28383","journal-title":"Mov Disord"},{"key":"1797_CR15","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3389\/fncel.2019.00058","volume":"13","author":"M Elkouris","year":"2019","unstructured":"Elkouris M, Kouroupi G, Vourvoukelis A, Papagiannakis N, Kaltezioti V, Matsas R, Stefanis L, Xilouri M, Politis PK (2019) Long non-coding RNAs associated with neurodegeneration-linked genes are reduced in Parkinson\u2019s disease patients. Front Cell Neurosci 13:58","journal-title":"Front Cell Neurosci"},{"key":"1797_CR16","doi-asserted-by":"publisher","first-page":"912","DOI":"10.3390\/biom10060912","volume":"10","author":"A Polissidis","year":"2020","unstructured":"Polissidis A, Petropoulou-Vathi L, Nakos-Bimpos M, Rideout HJ (2020) The future of targeted gene-based treatment strategies and biomarkers in Parkinson\u2019s disease. Biomolecules 10:912. https:\/\/doi.org\/10.3390\/biom10060912","journal-title":"Biomolecules"},{"key":"1797_CR17","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.neulet.2018.09.059","volume":"687","author":"H Ding","year":"2018","unstructured":"Ding H, Cui X-Y, Cui S-Y, Ye H, Hu X, Zhao H-L, Liu Y-T, Zhang Y-H (2018) Depression-like behaviors induced by chronic corticosterone exposure via drinking water: time-course analysis. Neurosci Lett 687:202\u2013206. https:\/\/doi.org\/10.1016\/j.neulet.2018.09.059","journal-title":"Neurosci Lett"},{"key":"1797_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.2019.10.1038\/nmeth.2019","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B, Tinevez J-Y, White DJ, Hartenstein V, Eliceiri K, Tomancak P, Cardona A (2012) Fiji - an Open Source platform for biological image analysis. Nat Methods. https:\/\/doi.org\/10.1038\/nmeth.2019.10.1038\/nmeth.2019","journal-title":"Nat Methods"},{"key":"1797_CR19","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1089\/neu.2011.2106","volume":"29","author":"ZZ Khaing","year":"2012","unstructured":"Khaing ZZ, Geissler SA, Jiang S, Milman BD, Aguilar SV, Schmidt CE, Schallert T (2012) Assessing forelimb function after unilateral cervical spinal cord injury: novel forelimb tasks predict lesion severity and recovery. J Neurotrauma 29:488\u2013498. https:\/\/doi.org\/10.1089\/neu.2011.2106","journal-title":"J Neurotrauma"},{"key":"1797_CR20","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1080\/15548627.2016.1214777","volume":"12","author":"M Xilouri","year":"2016","unstructured":"Xilouri M, Brekk OR, Polissidis A, Chrysanthou-Piterou M, Kloukina I, Stefanis L (2016) Impairment of chaperone-mediated autophagy induces dopaminergic neurodegeneration in rats. Autophagy 12:2230\u20132247. https:\/\/doi.org\/10.1080\/15548627.2016.1214777","journal-title":"Autophagy"},{"key":"1797_CR21","volume-title":"The rat brain in stereotaxic coordinates - the new coronal set","author":"G Paxinos","year":"2004","unstructured":"Paxinos G, Watson C (2004) The rat brain in stereotaxic coordinates - the new coronal set. Elsevier, Amsterdam"},{"key":"1797_CR22","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods San Diego Calif 25:402\u2013408. https:\/\/doi.org\/10.1006\/meth.2001.1262","journal-title":"Methods San Diego Calif"},{"key":"1797_CR23","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/bs.acc.2022.07.004","volume":"111","author":"A Bougea","year":"2022","unstructured":"Bougea A, Stefanis L, Chrousos G (2022) Stress system and related biomarkers in Parkinson\u2019s disease. Adv Clin Chem 111:177\u2013215. https:\/\/doi.org\/10.1016\/bs.acc.2022.07.004","journal-title":"Adv Clin Chem"},{"key":"1797_CR24","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/mds.21803","volume":"23","author":"JSAM Reijnders","year":"2008","unstructured":"Reijnders JSAM, Ehrt U, Weber WEJ, Aarsland D, Leentjens AFG (2008) A systematic review of prevalence studies of depression in Parkinson\u2019s disease. Mov Disord Off J Mov Disord Soc 23:183\u2013189. https:\/\/doi.org\/10.1002\/mds.21803","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"1797_CR25","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1111\/eci.12554","volume":"45","author":"NC Nicolaides","year":"2015","unstructured":"Nicolaides NC, Lamprokostopoulou A, Polyzos A, Kino T, Katsantoni E, Triantafyllou P, Christophoridis A, Katzos G, Dracopoulou M, Sertedaki A, Chrousos GP, Charmandari E (2015) Transient generalized glucocorticoid hypersensitivity. Eur J Clin Invest 45:1306\u20131315. https:\/\/doi.org\/10.1111\/eci.12554","journal-title":"Eur J Clin Invest"},{"key":"1797_CR26","doi-asserted-by":"publisher","first-page":"10839","DOI":"10.3390\/ijms221910839","volume":"22","author":"NC Nicolaides","year":"2021","unstructured":"Nicolaides NC, Charmandari E (2021) Primary generalized glucocorticoid resistance and hypersensitivity syndromes: a 2021 Update. Int J Mol Sci 22:10839. https:\/\/doi.org\/10.3390\/ijms221910839","journal-title":"Int J Mol Sci"},{"key":"1797_CR27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/BF00319704","volume":"238","author":"G Bellomo","year":"1991","unstructured":"Bellomo G, Santambrogio L, Fiacconi M, Scarponi AM, Ciuffetti G (1991) Plasma profiles of adrenocorticotropic hormone, cortisol, growth hormone and prolactin in patients with untreated Parkinson\u2019s disease. J Neurol 238:19\u201322. https:\/\/doi.org\/10.1007\/BF00319704","journal-title":"J Neurol"},{"key":"1797_CR28","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1159\/000097237","volume":"3","author":"G Stypu\u0142a","year":"1996","unstructured":"Stypu\u0142a G, Kunert-Radek J, Stepie\u0144 H, Zyli\u0144ska K, Pawlikowski M (1996) Evaluation of interleukins, ACTH, cortisol and prolactin concentrations in the blood of patients with Parkinson\u2019s disease. NeuroImmunoModulation 3:131\u2013134. https:\/\/doi.org\/10.1159\/000097237","journal-title":"NeuroImmunoModulation"},{"key":"1797_CR29","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/0006-3223(90)90525-7","volume":"27","author":"JM Rabey","year":"1990","unstructured":"Rabey JM, Scharf M, Oberman Z, Zohar M, Graff E (1990) Cortisol, ACTH, and beta-endorphin after dexamethasone administration in Parkinson\u2019s dementia. Biol Psychiatry 27:581\u2013591. https:\/\/doi.org\/10.1016\/0006-3223(90)90525-7","journal-title":"Biol Psychiatry"},{"key":"1797_CR30","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0197-4580(97)80309-0","volume":"18","author":"A Hartmann","year":"1997","unstructured":"Hartmann A, Veldhuis JD, Deuschle M, Standhardt H, Heuser I (1997) Twenty-four hour cortisol release profiles in patients with Alzheimer\u2019s and Parkinson\u2019s disease compared to normal controls: ultradian secretory pulsatility and diurnal variation. Neurobiol Aging 18:285\u2013289. https:\/\/doi.org\/10.1016\/S0197-4580(97)80309-0","journal-title":"Neurobiol Aging"},{"key":"1797_CR31","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1600-0404.1998.tb00614.x","volume":"97","author":"A Charlett","year":"1998","unstructured":"Charlett A, Dobbs RJ, Purkiss AG, Wrighe DJ, Peterson DW, Weller C, Dobbs SM (1998) Cortisol is higher in parkinsonism and associated with gait deficit. Acta Neurol Scand 97:77\u201385. https:\/\/doi.org\/10.1111\/j.1600-0404.1998.tb00614.x","journal-title":"Acta Neurol Scand"},{"key":"1797_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF02252658","volume":"7","author":"R Volpi","year":"1994","unstructured":"Volpi R, Caffarra P, Scaglioni A, Maestri D, Chiodera P, Coiro V (1994) Restoration of ACTH\/cortisol and LH responses to naloxone by chronic dopaminergic treatment in Parkinson\u2019s disease. J Neural Transm Park Dis Dement Sect 7:1\u201311. https:\/\/doi.org\/10.1007\/BF02252658","journal-title":"J Neural Transm Park Dis Dement Sect"},{"key":"1797_CR33","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1159\/000119394","volume":"35","author":"R Volpi","year":"1997","unstructured":"Volpi R, Caffarra P, Boni S, Scaglioni A, Malvezzi L, Saginario A, Chiodera P, Coiro V (1997) ACTH\/cortisol involvement in the serotonergic disorder affecting the parkinsonian brain. Neuropsychobiology 35:73\u201378. https:\/\/doi.org\/10.1159\/000119394","journal-title":"Neuropsychobiology"},{"key":"1797_CR34","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41531-024-00692-4","volume":"10","author":"A van der Heide","year":"2024","unstructured":"van der Heide A, Dommershuijsen LJ, Puhlmann LMC, Kalisch R, Bloem BR, Speckens AEM, Helmich RC (2024) Predictors of stress resilience in Parkinson\u2019s disease and associations with symptom progression. NPJ Park Dis 10:81. https:\/\/doi.org\/10.1038\/s41531-024-00692-4","journal-title":"NPJ Park Dis"},{"key":"1797_CR35","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1093\/brain\/awm090","volume":"130","author":"R Fronczek","year":"2007","unstructured":"Fronczek R, Overeem S, Lee SYY, Hegeman IM, van Pelt J, van Duinen SG, Lammers GJ, Swaab DF (2007) Hypocretin (orexin) loss in Parkinson\u2019s disease. Brain J Neurol 130:1577\u20131585. https:\/\/doi.org\/10.1093\/brain\/awm090","journal-title":"Brain J Neurol"},{"key":"1797_CR36","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1093\/brain\/awm097","volume":"130","author":"TC Thannickal","year":"2007","unstructured":"Thannickal TC, Lai Y-Y, Siegel JM (2007) Hypocretin (orexin) cell loss in Parkinson\u2019s disease*. Brain 130:1586\u20131595. https:\/\/doi.org\/10.1093\/brain\/awm097","journal-title":"Brain"},{"key":"1797_CR37","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s00702-010-0508-2","volume":"118","author":"H Braak","year":"1996","unstructured":"Braak H, Thal DR (1996) Del Tredici K (2011) Nerve cells immunoreactive for p62 in select hypothalamic and brainstem nuclei of controls and Parkinson\u2019s disease cases. J Neural Transm Vienna Austria 118:809\u2013819. https:\/\/doi.org\/10.1007\/s00702-010-0508-2","journal-title":"J Neural Transm Vienna Austria"},{"key":"1797_CR38","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3389\/fnmol.2018.00321","volume":"11","author":"E Cuvelier","year":"2018","unstructured":"Cuvelier E, M\u00e9quinion M, Leghay C, Sibran W, Stievenard A, Sarchione A, Bonte M-A, Vanbesien-Mailliot C, Viltart O, Saitoski K, Caron E, Labarthe A, Comptdaer T, Semaille P, Carri\u00e9 H, Mutez E, Gressier B, Dest\u00e9e A, Chartier-Harlin M-C, Belarbi K (2018) Overexpression of wild-type human alpha-synuclein causes metabolism abnormalities in Thy1-aSYN transgenic mice. Front Mol Neurosci 11:321","journal-title":"Front Mol Neurosci"},{"key":"1797_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41531-021-00203-9","volume":"7","author":"LMA Oliveira","year":"2021","unstructured":"Oliveira LMA, Gasser T, Edwards R, Zweckstetter M, Melki R, Stefanis L, Lashuel HA, Sulzer D, Vekrellis K, Halliday GM, Tomlinson JJ, Schlossmacher M, Jensen PH, Schulze-Hentrich J, Riess O, Hirst WD, El-Agnaf O, Mollenhauer B, Lansbury P, Outeiro TF (2021) Alpha-synuclein research: defining strategic moves in the battle against Parkinson\u2019s disease. NPJ Park Dis 7:1\u201323. https:\/\/doi.org\/10.1038\/s41531-021-00203-9","journal-title":"NPJ Park Dis"},{"key":"1797_CR40","doi-asserted-by":"publisher","first-page":"16533","DOI":"10.1038\/s41598-017-15813-8","volume":"7","author":"M Karampetsou","year":"2017","unstructured":"Karampetsou M, Ardah MT, Semitekolou M, Polissidis A, Samiotaki M, Kalomoiri M, Majbour N, Xanthou G, El-Agnaf OMA, Vekrellis K (2017) Phosphorylated exogenous alpha-synuclein fibrils exacerbate pathology and induce neuronal dysfunction in mice. Sci Rep 7:16533. https:\/\/doi.org\/10.1038\/s41598-017-15813-8","journal-title":"Sci Rep"},{"key":"1797_CR41","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41531-023-00444-w","volume":"9","author":"N Ramalingam","year":"2023","unstructured":"Ramalingam N, Jin S-X, Moors TE, Fonseca-Ornelas L, Shimanaka K, Lei S, Cam HP, Watson AH, Brontesi L, Ding L, Hacibaloglu DY, Jiang H, Choi SJ, Kanter E, Liu L, Bartels T, Nuber S, Sulzer D, Mosharov EV, Chen WV, Li S, Selkoe DJ, Dettmer U (2023) Dynamic physiological \u03b1-synuclein S129 phosphorylation is driven by neuronal activity. NPJ Park Dis 9:4. https:\/\/doi.org\/10.1038\/s41531-023-00444-w","journal-title":"NPJ Park Dis"},{"key":"1797_CR42","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1212\/wnl.37.6.905","volume":"37","author":"PJ Whitehouse","year":"1987","unstructured":"Whitehouse PJ, Vale WW, Zweig RM, Singer HS, Mayeux R, Kuhar MJ, Price DL, De Souza EB (1987) Reductions in corticotropin releasing factor-like immunoreactivity in cerebral cortex in Alzheimer\u2019s disease, Parkinson\u2019s disease, and progressive supranuclear palsy. Neurology 37:905\u2013909. https:\/\/doi.org\/10.1212\/wnl.37.6.905","journal-title":"Neurology"},{"key":"1797_CR43","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1097\/00004647-200202000-00011","volume":"22","author":"V Sossi","year":"2002","unstructured":"Sossi V, de La Fuente-Fern\u00e1ndez R, Holden JE, Doudet DJ, McKenzie J, Stoessl AJ, Ruth TJ (2002) Increase in dopamine turnover occurs early in Parkinson\u2019s disease: evidence from a new modeling approach to PET 18 F-fluorodopa data. J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab 22:232\u2013239. https:\/\/doi.org\/10.1097\/00004647-200202000-00011","journal-title":"J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab"},{"key":"1797_CR44","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1038\/nn766","volume":"4","author":"B Roozendaal","year":"2001","unstructured":"Roozendaal B, Phillips RG, Power AE, Brooke SM, Sapolsky RM, McGaugh JL (2001) Memory retrieval impairment induced by hippocampal CA3 lesions is blocked by adrenocortical suppression. Nat Neurosci 4:1169\u20131171. https:\/\/doi.org\/10.1038\/nn766","journal-title":"Nat Neurosci"},{"key":"1797_CR45","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1196\/annals.1410.012","volume":"1148","author":"R Jankord","year":"2008","unstructured":"Jankord R, Herman JP (2008) Limbic regulation of hypothalamo-pituitary-adrenocortical function during acute and chronic stress. Ann N Y Acad Sci 1148:64\u201373. https:\/\/doi.org\/10.1196\/annals.1410.012","journal-title":"Ann N Y Acad Sci"},{"key":"1797_CR46","first-page":"29","volume":"56","author":"A Adamczyk","year":"2005","unstructured":"Adamczyk A, Solecka J, Strosznajder JB (2005) Expression of alpha-synuclein in different brain parts of adult and aged rats. J Physiol Pharmacol Off J Pol Physiol Soc 56:29\u201337","journal-title":"J Physiol Pharmacol Off J Pol Physiol Soc"},{"key":"1797_CR47","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/mds.26112","volume":"30","author":"TJ van Mierlo","year":"2015","unstructured":"van Mierlo TJ, Chung C, Foncke EM, Berendse HW, van den Heuvel OA (2015) Depressive symptoms in Parkinson\u2019s disease are related to decreased hippocampus and amygdala volume. Mov Disord 30:245\u2013252. https:\/\/doi.org\/10.1002\/mds.26112","journal-title":"Mov Disord"},{"issue":"Suppl 1","key":"1797_CR48","doi-asserted-by":"publisher","first-page":"S119","DOI":"10.1016\/j.parkreldis.2015.09.004","volume":"22","author":"RF Pfeiffer","year":"2016","unstructured":"Pfeiffer RF (2016) Non-motor symptoms in Parkinson\u2019s disease. Parkinsonism Relat Disord 22(Suppl 1):S119-122. https:\/\/doi.org\/10.1016\/j.parkreldis.2015.09.004","journal-title":"Parkinsonism Relat Disord"},{"key":"1797_CR49","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.neuroscience.2004.03.036","volume":"126","author":"Y Chen","year":"2004","unstructured":"Chen Y, Brunson KL, Adelmann G, Bender RA, Frotscher M, Baram TZ (2004) Hippocampal corticotropin releasing hormone: pre- and postsynaptic location and release by stress. Neuroscience 126:533\u2013540. https:\/\/doi.org\/10.1016\/j.neuroscience.2004.03.036","journal-title":"Neuroscience"},{"key":"1797_CR50","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.celrep.2019.09.037","volume":"29","author":"Y Koutmani","year":"2019","unstructured":"Koutmani Y, Gampierakis IA, Polissidis A, Ximerakis M, Koutsoudaki PN, Polyzos A, Agrogiannis G, Karaliota S, Thomaidou D, Rubin LL, Politis PK, Karalis KP (2019) CRH promotes the neurogenic activity of neural stem cells in the adult hippocampus. Cell Rep 29:932-945.e7. https:\/\/doi.org\/10.1016\/j.celrep.2019.09.037","journal-title":"Cell Rep"},{"key":"1797_CR51","doi-asserted-by":"publisher","first-page":"e13129","DOI":"10.1111\/eci.13129","volume":"49","author":"NC Nicolaides","year":"2019","unstructured":"Nicolaides NC, Polyzos A, Koniari E, Lamprokostopoulou A, Papageorgiou I, Golfinopoulou E, Papathanasiou C, Sertedaki A, Thanos D, Chrousos GP, Charmandari E (2019) Transcriptomics in tissue glucocorticoid sensitivity. Eur J Clin Invest 49:e13129. https:\/\/doi.org\/10.1111\/eci.13129","journal-title":"Eur J Clin Invest"},{"key":"1797_CR52","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/nrendo.2009.106","volume":"5","author":"GP Chrousos","year":"2009","unstructured":"Chrousos GP (2009) Stress and disorders of the stress system. Nat Rev Endocrinol 5:374\u2013381. https:\/\/doi.org\/10.1038\/nrendo.2009.106","journal-title":"Nat Rev Endocrinol"},{"key":"1797_CR53","doi-asserted-by":"publisher","first-page":"3682","DOI":"10.1016\/j.celrep.2020.02.099","volume":"30","author":"E Siopi","year":"2020","unstructured":"Siopi E, Chevalier G, Katsimpardi L, Saha S, Bigot M, Moigneu C, Eberl G, Lledo P-M (2020) Changes in gut microbiota by chronic stress impair the efficacy of fluoxetine. Cell Rep 30:3682-3690.e6. https:\/\/doi.org\/10.1016\/j.celrep.2020.02.099","journal-title":"Cell Rep"},{"key":"1797_CR54","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/0014-2999(92)90830-W","volume":"222","author":"Y Watanabe","year":"1992","unstructured":"Watanabe Y, Gould E, Daniels DC, Cameron H, McEwen BS (1992) Tianeptine attenuates stress-induced morphological changes in the hippocampus. Eur J Pharmacol 222:157\u2013162. https:\/\/doi.org\/10.1016\/0014-2999(92)90830-W","journal-title":"Eur J Pharmacol"},{"key":"1797_CR55","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1037\/0735-7044.110.6.1321","volume":"110","author":"CD Conrad","year":"1996","unstructured":"Conrad CD, Galea LA, Kuroda Y, McEwen BS (1996) Chronic stress impairs rat spatial memory on the Y maze, and this effect is blocked by tianeptine pretreatment. Behav Neurosci 110:1321\u20131334. https:\/\/doi.org\/10.1037\/0735-7044.110.6.1321","journal-title":"Behav Neurosci"},{"key":"1797_CR56","doi-asserted-by":"publisher","first-page":"re5","DOI":"10.1126\/stke.2252004re5","volume":"2004","author":"DS Charney","year":"2004","unstructured":"Charney DS, Manji HK (2004) Life stress, genes, and depression: multiple pathways lead to increased risk and new opportunities for intervention. Sci STKE 2004:re5. https:\/\/doi.org\/10.1126\/stke.2252004re5","journal-title":"Sci STKE"},{"key":"1797_CR57","doi-asserted-by":"publisher","first-page":"633398","DOI":"10.3389\/fnmol.2021.633398","volume":"14","author":"W Gong","year":"2021","unstructured":"Gong W, Liao W, Fang C, Liu Y, Xie H, Yi F, Huang R, Wang L, Zhou J (2021) Analysis of chronic mild stress-induced hypothalamic proteome: identification of protein dysregulations associated with vulnerability and resiliency to depression or anxiety. Front Mol Neurosci 14:633398. https:\/\/doi.org\/10.3389\/fnmol.2021.633398","journal-title":"Front Mol Neurosci"},{"key":"1797_CR58","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1111\/j.1460-9568.2008.06177.x","volume":"27","author":"LK Smith","year":"2008","unstructured":"Smith LK, Jadavji NM, Colwell KL, Katrina Perehudoff S, Metz GA (2008) Stress accelerates neural degeneration and exaggerates motor symptoms in a rat model of Parkinson\u2019s disease. Eur J Neurosci 27:2133\u20132146. https:\/\/doi.org\/10.1111\/j.1460-9568.2008.06177.x","journal-title":"Eur J Neurosci"},{"key":"1797_CR59","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1002\/ana.410180506","volume":"18","author":"AM Snyder","year":"1985","unstructured":"Snyder AM, Stricker EM, Zigmond MJ (1985) Stress-induced neurological impairments in an animal model of parkinsonism. Ann Neurol 18:544\u2013551. https:\/\/doi.org\/10.1002\/ana.410180506","journal-title":"Ann Neurol"},{"key":"1797_CR60","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0140-6736(80)90015-X","volume":"316","author":"FB Gibberd","year":"1980","unstructured":"Gibberd FB, Simmonds JP (1980) Neurological disease in ex-far-east prisoners of war. The Lancet 316:135\u2013137. https:\/\/doi.org\/10.1016\/S0140-6736(80)90015-X","journal-title":"The Lancet"},{"key":"1797_CR61","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1212\/WNL.40.2.273","volume":"40","author":"CG Goetz","year":"1990","unstructured":"Goetz CG, Tanner C, Penn RD, Stebbins GT, Gilley DW, Shannon KM, Klawans HL, Comelia CL, Wilson RS, Witt T (1990) Adrenal medullary transplant to the striatum of patients with advanced Parkinson\u2019s disease: 1-year motor and psychomotor data. Neurology 40:273\u2013273. https:\/\/doi.org\/10.1212\/WNL.40.2.273","journal-title":"Neurology"},{"key":"1797_CR62","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.tins.2007.03.006","volume":"30","author":"A Bj\u00f6rklund","year":"2007","unstructured":"Bj\u00f6rklund A, Dunnett SB (2007) Dopamine neuron systems in the brain: an update. Trends Neurosci 30:194\u2013202. https:\/\/doi.org\/10.1016\/j.tins.2007.03.006","journal-title":"Trends Neurosci"},{"key":"1797_CR63","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1002\/jnr.22611","volume":"89","author":"HA Lam","year":"2011","unstructured":"Lam HA, Wu N, Cely I, Kelly RL, Hean S, Richter F, Magen I, Cepeda C, Ackerson LC, Walwyn W, Masliah E, Chesselet M-F, Levine MS, Maidment NT (2011) Elevated tonic extracellular dopamine concentration and altered dopamine modulation of synaptic activity precede dopamine loss in the striatum of mice overexpressing human \u03b1-synuclein. J Neurosci Res 89:1091\u20131102. https:\/\/doi.org\/10.1002\/jnr.22611","journal-title":"J Neurosci Res"},{"key":"1797_CR64","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s13311-012-0104-2","volume":"9","author":"M-F Chesselet","year":"2012","unstructured":"Chesselet M-F, Richter F, Zhu C, Magen I, Watson MB, Subramaniam SR (2012) A progressive mouse model of Parkinson\u2019s disease: the Thy1-aSyn (\u201cLine 61\u201d) mice. Neurotherapeutics 9:297\u2013314. https:\/\/doi.org\/10.1007\/s13311-012-0104-2","journal-title":"Neurotherapeutics"},{"key":"1797_CR65","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.nbd.2007.09.004","volume":"29","author":"RY Moore","year":"2008","unstructured":"Moore RY, Whone AL, Brooks DJ (2008) Extrastriatal monoamine neuron function in Parkinson\u2019s disease: an 18F-dopa PET study. Neurobiol Dis 29:381\u2013390. https:\/\/doi.org\/10.1016\/j.nbd.2007.09.004","journal-title":"Neurobiol Dis"},{"key":"1797_CR66","doi-asserted-by":"publisher","first-page":"9262","DOI":"10.1074\/jbc.M109.081125","volume":"285","author":"H-J Lee","year":"2010","unstructured":"Lee H-J, Suk J-E, Patrick C, Bae E-J, Cho J-H, Rho S, Hwang D, Masliah E, Lee S-J (2010) Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies. J Biol Chem 285:9262\u20139272. https:\/\/doi.org\/10.1074\/jbc.M109.081125","journal-title":"J Biol Chem"},{"key":"1797_CR67","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.neuroscience.2010.12.005","volume":"175","author":"S Walsh","year":"2011","unstructured":"Walsh S, Finn DP, Dowd E (2011) Time-course of nigrostriatal neurodegeneration and neuroinflammation in the 6-hydroxydopamine-induced axonal and terminal lesion models of Parkinson\u2019s disease in the rat. Neuroscience 175:251\u2013261. https:\/\/doi.org\/10.1016\/j.neuroscience.2010.12.005","journal-title":"Neuroscience"},{"key":"1797_CR68","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/jnc.13684","volume":"139","author":"I Morales","year":"2016","unstructured":"Morales I, Sanchez A, Rodriguez-Sabate C, Rodriguez M (2016) The astrocytic response to the dopaminergic denervation of the striatum. J Neurochem 139:81\u201395. https:\/\/doi.org\/10.1111\/jnc.13684","journal-title":"J Neurochem"},{"key":"1797_CR69","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1212\/wnl.38.8.1285","volume":"38","author":"PL McGeer","year":"1988","unstructured":"McGeer PL, Itagaki S, Boyes BE, McGeer EG (1988) Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains. Neurology 38:1285\u20131291. https:\/\/doi.org\/10.1212\/wnl.38.8.1285","journal-title":"Neurology"},{"key":"1797_CR70","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1007\/s00401-003-0766-2","volume":"106","author":"K Imamura","year":"2003","unstructured":"Imamura K, Hishikawa N, Sawada M, Nagatsu T, Yoshida M, Hashizume Y (2003) Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson\u2019s disease brains. Acta Neuropathol (Berl) 106:518\u2013526. https:\/\/doi.org\/10.1007\/s00401-003-0766-2","journal-title":"Acta Neuropathol (Berl)"},{"key":"1797_CR71","doi-asserted-by":"publisher","first-page":"6632","DOI":"10.1073\/pnas.1017820108","volume":"108","author":"F Ros-Bernal","year":"2011","unstructured":"Ros-Bernal F, Hunot S, Herrero MT, Parnadeau S, Corvol J-C, Lu L, Alvarez-Fischer D, Carrillo-de Sauvage MA, Saurini F, Coussieu C, Kinugawa K, Prigent A, H\u00f6glinger G, Hamon M, Tronche F, Hirsch EC, Vyas S (2011) Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonism. Proc Natl Acad Sci USA 108:6632\u20136637. https:\/\/doi.org\/10.1073\/pnas.1017820108","journal-title":"Proc Natl Acad Sci USA"},{"key":"1797_CR72","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.3233\/JPD-202465","volume":"11","author":"S Villar-Conde","year":"2021","unstructured":"Villar-Conde S, Astillero-Lopez V, Gonzalez-Rodriguez M, Villanueva-Anguita P, Saiz-Sanchez D, Martinez-Marcos A, Flores-Cuadrado A, Ubeda-Ba\u00f1on I (2021) The human hippocampus in Parkinson\u2019s disease: an integrative stereological and proteomic study. J Park Dis 11:1345\u20131365. https:\/\/doi.org\/10.3233\/JPD-202465","journal-title":"J Park Dis"},{"key":"1797_CR73","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1523\/JNEUROSCI.3047-16.2016","volume":"37","author":"DH Adamowicz","year":"2017","unstructured":"Adamowicz DH, Roy S, Salmon DP, Galasko DR, Hansen LA, Masliah E, Gage FH (2017) Hippocampal \u03b1-synuclein in dementia with lewy bodies contributes to memory impairment and is consistent with spread of pathology. J Neurosci 37:1675\u20131684. https:\/\/doi.org\/10.1523\/JNEUROSCI.3047-16.2016","journal-title":"J Neurosci"},{"key":"1797_CR74","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Tredici KD, R\u00fcb U, de Vos RAI, Jansen Steur ENH, Braak E (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24:197\u2013211. https:\/\/doi.org\/10.1016\/S0197-4580(02)00065-9","journal-title":"Neurobiol Aging"},{"key":"1797_CR75","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00401-008-0344-8","volume":"115","author":"G Halliday","year":"2008","unstructured":"Halliday G, Hely M, Reid W, Morris J (2008) The progression of pathology in longitudinally followed patients with Parkinson\u2019s disease. Acta Neuropathol (Berl) 115:409\u2013415. https:\/\/doi.org\/10.1007\/s00401-008-0344-8","journal-title":"Acta Neuropathol (Berl)"},{"key":"1797_CR76","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/brain\/aws358","volume":"136","author":"S Nuber","year":"2013","unstructured":"Nuber S, Harmuth F, Kohl Z, Adame A, Trejo M, Sch\u00f6nig K, Zimmermann F, Bauer C, Casadei N, Giel C, Calaminus C, Pichler BJ, Jensen PH, M\u00fcller CP, Amato D, Kornhuber J, Teismann P, Yamakado H, Takahashi R, Winkler J, Masliah E, Riess O (2013) A progressive dopaminergic phenotype associated with neurotoxic conversion of \u03b1-synuclein in BAC-transgenic rats. Brain 136:412\u2013432. https:\/\/doi.org\/10.1093\/brain\/aws358","journal-title":"Brain"},{"key":"1797_CR77","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.nbd.2015.10.021","volume":"85","author":"Z Kohl","year":"2016","unstructured":"Kohl Z, Ben Abdallah N, Vogelgsang J, Tischer L, Deusser J, Amato D, Anderson S, M\u00fcller CP, Riess O, Masliah E, Nuber S, Winkler J (2016) Severely impaired hippocampal neurogenesis associates with an early serotonergic deficit in a BAC \u03b1-synuclein transgenic rat model of Parkinson\u2019s disease. Neurobiol Dis 85:206\u2013217. https:\/\/doi.org\/10.1016\/j.nbd.2015.10.021","journal-title":"Neurobiol Dis"},{"key":"1797_CR78","doi-asserted-by":"publisher","first-page":"e0191363","DOI":"10.1371\/journal.pone.0191363","volume":"13","author":"A Hooper","year":"2018","unstructured":"Hooper A, Fuller PM, Maguire J (2018) Hippocampal corticotropin-releasing hormone neurons support recognition memory and modulate hippocampal excitability. PLoS ONE 13:e0191363. https:\/\/doi.org\/10.1371\/journal.pone.0191363","journal-title":"PLoS ONE"},{"key":"1797_CR79","doi-asserted-by":"publisher","first-page":"6174","DOI":"10.1073\/pnas.81.19.6174","volume":"81","author":"RM Sapolsky","year":"1984","unstructured":"Sapolsky RM, Krey LC, McEwen BS (1984) Glucocorticoid-sensitive hippocampal neurons are involved in terminating the adrenocortical stress response. Proc Natl Acad Sci USA 81:6174\u20136177. https:\/\/doi.org\/10.1073\/pnas.81.19.6174","journal-title":"Proc Natl Acad Sci USA"},{"key":"1797_CR80","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/0896-6273(88)90136-5","volume":"1","author":"JL Arriza","year":"1988","unstructured":"Arriza JL, Simerly RB, Swanson LW, Evans RM (1988) The neuronal mineralocorticoid receptor as a mediator of glucocorticoid response. Neuron 1:887\u2013900. https:\/\/doi.org\/10.1016\/0896-6273(88)90136-5","journal-title":"Neuron"},{"key":"1797_CR81","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/cphy.c130044","volume":"4","author":"E Gomez-Sanchez","year":"2014","unstructured":"Gomez-Sanchez E, Gomez-Sanchez CE (2014) The multifaceted mineralocorticoid receptor. Compr Physiol 4:965\u2013994. https:\/\/doi.org\/10.1002\/cphy.c130044","journal-title":"Compr Physiol"},{"key":"1797_CR82","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1210\/edrv-12-2-118","volume":"12","author":"L Jacobson","year":"1991","unstructured":"Jacobson L, Sapolsky R (1991) The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis. Endocr Rev 12:118\u2013134. https:\/\/doi.org\/10.1210\/edrv-12-2-118","journal-title":"Endocr Rev"},{"key":"1797_CR83","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1038\/nn.4086","volume":"18","author":"BS McEwen","year":"2015","unstructured":"McEwen BS, Bowles NP, Gray JD, Hill MN, Hunter RG, Karatsoreos IN, Nasca C (2015) Mechanisms of stress in the brain. Nat Neurosci 18:1353\u20131363. https:\/\/doi.org\/10.1038\/nn.4086","journal-title":"Nat Neurosci"},{"key":"1797_CR84","doi-asserted-by":"publisher","first-page":"11336","DOI":"10.1073\/pnas.1605246113","volume":"113","author":"KR Mifsud","year":"2016","unstructured":"Mifsud KR, Reul JMHM (2016) Acute stress enhances heterodimerization and binding of corticosteroid receptors at glucocorticoid target genes in the hippocampus. Proc Natl Acad Sci USA 113:11336\u201311341. https:\/\/doi.org\/10.1073\/pnas.1605246113","journal-title":"Proc Natl Acad Sci USA"},{"key":"1797_CR85","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/cne.903130312","volume":"313","author":"R Ahima","year":"1991","unstructured":"Ahima R, Krozowski Z, Harlan R (1991) Type I corticosteroid receptor-like immunoreactivity in the rat CNS: distribution and regulation by corticosteroids. J Comp Neurol 313:522\u2013538. https:\/\/doi.org\/10.1002\/cne.903130312","journal-title":"J Comp Neurol"},{"key":"1797_CR86","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1016\/j.neurobiolaging.2012.11.019","volume":"34","author":"Q Wang","year":"2013","unstructured":"Wang Q, Van Heerikhuize J, Aronica E, Kawata M, Seress L, Joels M, Swaab DF, Lucassen PJ (2013) Glucocorticoid receptor protein expression in human hippocampus; stability with age. Neurobiol Aging 34:1662\u20131673. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2012.11.019","journal-title":"Neurobiol Aging"},{"key":"1797_CR87","doi-asserted-by":"publisher","first-page":"6391686","DOI":"10.1155\/2016\/6391686","volume":"2016","author":"S Vyas","year":"2016","unstructured":"Vyas S, Rodrigues AJ, Silva JM, Tronche F, Almeida OFX, Sousa N, Sotiropoulos I (2016) Chronic stress and glucocorticoids: from neuronal plasticity to neurodegeneration. Neural Plast 2016:6391686. https:\/\/doi.org\/10.1155\/2016\/6391686","journal-title":"Neural Plast"},{"key":"1797_CR88","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3389\/fnana.2015.00032","volume":"9","author":"M-T Herrero","year":"2015","unstructured":"Herrero M-T, Estrada C, Maatouk L, Vyas S (2015) Inflammation in Parkinson\u2019s disease: role of glucocorticoids. Front Neuroanat 9:32. https:\/\/doi.org\/10.3389\/fnana.2015.00032","journal-title":"Front Neuroanat"},{"key":"1797_CR89","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1093\/toxsci\/kfz082","volume":"170","author":"BR De Miranda","year":"2019","unstructured":"De Miranda BR, Fazzari M, Rocha EM, Castro S, Greenamyre JT (2019) Sex Differences in rotenone sensitivity reflect the male-to-female ratio in human Parkinson\u2019s disease incidence. Toxicol Sci Off J Soc Toxicol 170:133\u2013143. https:\/\/doi.org\/10.1093\/toxsci\/kfz082","journal-title":"Toxicol Sci Off J Soc Toxicol"},{"key":"1797_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresrev.2007.02.006","author":"M Bs","year":"2007","unstructured":"Bs M, Ta M (2007) Hippocampal formation: shedding light on the influence of sex and stress on the brain. Brain Res Rev. https:\/\/doi.org\/10.1016\/j.brainresrev.2007.02.006","journal-title":"Brain Res Rev"},{"key":"1797_CR91","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/jnr.23963","volume":"95","author":"JB Becker","year":"2017","unstructured":"Becker JB, McClellan ML, Reed BG (2017) Sex differences, gender and addiction. J Neurosci Res 95:136\u2013147. https:\/\/doi.org\/10.1002\/jnr.23963","journal-title":"J Neurosci Res"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-024-01797-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-024-01797-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-024-01797-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T08:07:22Z","timestamp":1718611642000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-024-01797-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,17]]},"references-count":91,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1797"],"URL":"https:\/\/doi.org\/10.1186\/s40478-024-01797-w","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,17]]},"assertion":[{"value":"27 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"100"}}